论文部分内容阅读
重症肌无力常引起眼球运动功能障碍,且用抗胆碱酯酸剂治疗效果不佳。眼肌型重症肌无力(OMG)在发病二年内可以是局限的,但约44％～53％的OMG可发展为全身型重症肌无力(GMG),目前的检查手段尚不能预测那些OMG将发展为威胁生命的、需特殊治疗(如胸腺切除)的GMG。
Myasthenia gravis often cause eye movement dysfunction, and the use of anticholinergic acid treatment ineffective. Ocular muscular myasthenia gravis (OMG) can be limited within two years of onset, but about 44-53% of OMG develop systemic myasthenia gravis (GMG) and the current test is not yet able to predict which OMGs will develop A life-threatening GMG that requires special treatment (such as thymectomy).